rs1555605077
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003079.5(SMARCE1):c.1156A>G(p.Asn386Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,596 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. N386N) has been classified as Likely benign.
Frequency
Consequence
NM_003079.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial meningiomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, G2P, Ambry Genetics
- Coffin-Siris syndrome 5Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- Coffin-Siris syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial multiple meningiomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMARCE1 | NM_003079.5 | c.1156A>G | p.Asn386Asp | missense_variant | Exon 11 of 11 | ENST00000348513.12 | NP_003070.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCE1 | ENST00000348513.12 | c.1156A>G | p.Asn386Asp | missense_variant | Exon 11 of 11 | 1 | NM_003079.5 | ENSP00000323967.6 | ||
| ENSG00000264058 | ENST00000476049.1 | n.*1504A>G | non_coding_transcript_exon_variant | Exon 13 of 13 | 5 | ENSP00000463483.1 | ||||
| ENSG00000264058 | ENST00000476049.1 | n.*1504A>G | 3_prime_UTR_variant | Exon 13 of 13 | 5 | ENSP00000463483.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461596Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727120 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial meningioma Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with aspartic acid, which is acidic and polar, at codon 386 of the SMARCE1 protein (p.Asn386Asp). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SMARCE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 532239). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SMARCE1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.N386D variant (also known as c.1156A>G), located in coding exon 10 of the SMARCE1 gene, results from an A to G substitution at nucleotide position 1156. The asparagine at codon 386 is replaced by aspartic acid, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at